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The entry of the United States into World War II, with exposure
of Army troops to epidemic (louse-borne) typhus fever in many parts
of the world, called for the use of adequate protective measures against
this disease. One important aspect of this protection was the compulsory
immunization with epidemic typhus vaccine of all soldiers going to, or
stationed in, areas where epidemic typhus was present or suspected.
The excellent protection afforded U. S. Army personnel by this
prophylactic immunization has already been reported by Sadusk.20
Similar information, including the incidence of typhus fever in the U. S.
Army during the war years (1942-46 inclusive), notes on the severity of
the disease and modification of the clinical course in a limited number of
cases, and remarks on the serological diagnosis of typhus in patients
who have been inoculated with vaccine prior to onset of the disease,
are presented here.
Epidemic typhus vaccine
It was early appreciated that persons recovering from epidemic
typhus fever exhibited evidence of considerable immunity to subsequent
reinfection with this disease and efforts were therefore made, in the
absence of adequate protection from killed vaccines,2 13 to produce a
subclinical or modified infection with the causative organisms. The
record of the use of living typhus vaccine presents a series of frank
failures. Investigations based on the use of "attenuated" murine typhus
strains likewise lead to results of doubtful value; satisfactory immunity
was developed only attheprice and riskof apatientdeveloping an active
infection with murine typhus. Some patients died and this danger,
together with other drawbacks of the use of a living vaccine, have been
pointed out by Dyer' and by Sadusk and Kuhlenbeck.2' The latter
authors gave an account of difficulties encountered by Japanese health
authorities in 1943 following the administration of a biliated living
* From the Department of Internal Medicine, Yale University School of Medicine.
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murine typhus vaccine. In a group of 290 persons so inoculated, 218
(70 per cent) developed symptoms of murine typhus fever and one of
these persons died from the disease.
With the growing realization of the dangers of the use of living
vaccines, increasing efforts were directed toward the study of killed
vaccines. The early work of da Rocha Lima"8 and of Weigl26 on the use
of killed suspensions of infected lice or infected louse feces suggested
that acquired immunity could be attained. However, these methods,
along with the use of killed suspensions of organisms obtained from
the peritoneal cavity of the rat29 or rodent lungs,3'8 were not practical
for large-scale immunization.
Following the studies of Cox' which demonstrated that rickettsiae
of the Rocky Mountain spotted fever and typhus groups could be grown
in the yolk-sac membrane of the developing chick embryo, Cox and
Bell5 prepared an epidemic typhus vaccine based upon the use of this
tissue as a culture medium. This vaccine, consisting of a killed sus-
pension of R. prowazeki grown in the yolk-sac membrane of the chick
and purified by centrifugation, protected guinea-pigs against challenge
with the virus. Subsequent modifications, such as Craigie's ether extrac-
tion' and the use of a so-called "soluble antigen"17' 25 lead to a vaccine
that was satisfactory not only from the standpoint of potency but also
from the aspect of commercial production. Indeed, production in bio-
logical houses in the United States during the World War II years
reached as much as 75,000,000 cc. per year.
The epidemic typhus vaccine used by the U. S. Army consisted of a
10 per cent yolk-sac suspension of the Breinl strain of R. prowazeki,
extracted with ether. This vaccine contains both rickettsial bodies and
"soluble antigen."
Since early 1942 and throughout the war years all U. S. Army per-
sonnel going to, or stationed in, areas where epidemic typhus fever was
present or suspected received this vaccine. Up through 1943, the initial
vaccination consisted of three injections of typhus vaccine, 1.0 cc. each,
administered subcutaneously at an interval of from 7 to 10 days, with
stimulating or booster doses being given every 6 months in endemic
areas. With increase in potency due to improvement in production, the
initial immunization series was reduced in middle 1944 to 2 doses of
vaccine and the stimulating dose was given at the beginning and in
the middle of the typhus season (1 November and 1 February in the
northern hemisphere).
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Incidence and mortality of typhus fever following immunization
Until processing of almost 20,000,000 individual medical records
is completed in the Office of The Surgeon General, the most reliable
data on the Army's morbidity from typhus are those obtained from the
weekly summary known as the "Statistical Health Report" submitted by
each Army hospital and separate dispensary. These data, while reason-
ably accurate, must be regarded as preliminary.
For the greater part of the war period, epidemic typhus, murine
(endemic) typhus, and tsutsugamushi disease (scrub typhus) were in-
cluded in the Statistical Health Report under the term "Typhus Fever,"
without differentiation between the various members of the typhus
group. However, it is possible to obtain a fairly close approximation of
morbidity from the specific diseases by grouping the cases under one of
the three members of the typhus-like group according to geographic
locality. For instance, it is evident that all cases of "typhus fever" con-
tracted in and reported from the continental United States are murine
typhus. Likewise, from epidemiological data and detailed studies of
sampled case records, it is reasonable to suppose that cases of "typhus
fever" reported from the Southwest Pacific and China-Burma-India areas
are scrub typhus, although it is possible that a small number of these
may actually be murine typhus or even epidemic typhus. On a similar
basis, cases reported from the European, Mediterranean, and Africa-
Middle East theatres presumably fall into the epidemic typhus group.
Reported morbidity from 'Typhus Fever' in the entire U. S. Army*
during the period January 1942 through December 1945, inclusive,
is shown in Table 1. These data are expressed in cases per year and in
admission rates per 1,000 per year. On the right side of the table are
given the total number of cases of epidemic typhus, murine typhus, and
scrub typhus.
It can be seen that there were 64 cases of epidemic typhus, 603 cases
of murine typhus, and 6,685 cases of scrub typhus reported to the War
Department for the war years 1942-1945, inclusive.
Considering the repeated exposure of our troops, it is remarkable
that there were only 64 cases of epidemic typhus. However, it must be
pointed out that this low incidence cannot be necessarily attributed to
prophylactic immunization with typhus vaccine, since other methods of
prevention (notably the use of insecticide powder such as MYL and
* The author is indebted to the Medical Statistics Division, Office of The Surgeon
General, War Department, for the basic data from which this table was compiled.
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DDT to prevent lousiness) were routinely employed. Due to the
difficulty of setting up an adequately controlled experiment in a human
population on a sufficiently large scale, the question of whether or not
vaccine will effectively reduce the incidence of epidemic typhus has not
been conclusively demonstrated.
However, certain recent studies indicate that typhus vaccine pre-
pared from the yolk-sac membrane of the embryonated chicken egg
will prevent or at least materially reduce the incidence of naturally
acquired epidemic typhus. Both Stuart-Harris22 and Sachs 19 conclude
that the results of their studies oftyphus in the British Army suggest that
reduction in incidence is effected by such immunization.
In order to support his conclusion, Stuart-Harris shows that while
the total number of cases of typhus fever in the Middle East from
January to September 1943 and in North Africa from January to April
1943 prior to general immunization was 232, this number fell to a
total of 21 cases in Naples from January to March 1944 and in the
Middle East from January to June 1944 during which period general
immunization was practiced. Although the significance of these figures
might appear impressive at first glance, it is only fair to point out that
the civilian typhus epidemic in the Middle East (particularly Egypt)
in 1944 was on aconsiderably reduced scalecompared with that in 1943.
The observations of Sachs on typhus in the British Army in Iran
and Iraq support the studies of Stuart-Harris. Sachs found a typhus in-
cidence ofonly 0.37 per 1000 in an immunized group of 51,000 soldiers
who were heavily exposed to typhus during the course of a civilian
epidemic, which was in decided contrast to an incidence of 0.91 per
1000 in an unprotected group of 155,000 soldiers who were not as
heavily exposed as theprotected group. In his analysis, Sachs included in
the immunized group any individual who had received one or more
doses of vaccine. When he further analyzed his immunized series, Sachs
states that not a single individual who had been fully immunized (3
1 cc. doses of vaccine with a "stimulating" dose every 3 months) against
typhus for at least 6 weeks before exposure developed the disease.
Gilliam,"1 in an analysis of the effect of Cox type vaccine in prevent-
ing epidemic typhus among employees of the Cairo Fever Hospital at
Abassia, Egypt, during the period January-June of 1943, likewise pre-
sents evidence which suggests that adequate vaccination affords some
degree of protection against a subsequent attack of louse-borne typhus.
In a group of 879 employees of this hospital, all of whom were heavily
exposed to typhus during the period stated above, it appeared that 3
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doses of vaccine afforded some protection against an attack of the
disease, while one or two doses did not offer much protection against
actual attack despite evidence10 that such vaccination favorably modified
the severity of illness in those attacked. It is important to state that the
vaccine employed in this study was prepared in 1942. Vaccine as pro-
duced subsequently in 1943 and 1944 appeared to be of higher potency
than were earlier lots.
Despite the foregoing evidence, there still generally remains a
healthy skepticism concerning the effect of vaccine on reduction of in-
cidence of epidemic typhus. On the other hand, there appears to be
universal agreement as to the effect of such immunization in reducing
the case fatality rate. 7, 10, 12, 19, 22, 23
CLINICAL COMPARISON OF VACCINATED AND UNVACCINATED GROUPS
OF TYPHUS FEVER CASES AMONG CAIRO FEVER HOSPITAL EMPLOYEES
(AFTER ECKE ET AL)
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FIG. 1. Graphic representation of the clinical comparison of vaccinated and unvaccinated groups
of typhus fever cases among Cairo Fever Hospital employees (after Ecke et al.).
In a carefully controlled investigation carried out among vaccinated
and unvaccinated employees of the Cairo Fever Hospital, Ecke and his
colleagues'0 demonstrated a remarkable difference in both the case
fatality rate and the clinical severity of the disease. In a group of 44
216TYPHUS VACCINE IMMUNIZATION
cases occurring subsequent to immunization with Cox type ether-
extracted vaccine contrasted by these authors with a control group of
54 cases occurring without benefit of such prophylactic immunization,
there were no deaths in the vaccinated group, but in the unvaccinated
group there were 11 deaths. As to the severity of the disease, there were
27 cases classified as mild and 1 as severe in the vaccinated group; in
striking contrast to this in the unvaccinated group, there was only 1 case
classified as mild while 36 cases were classed as severe. Classified as mod-
erately severe, there were 16 cases in the vaccinated group and 17 cases
in the unvaccinated. The average age of both groups was 26.4 years.
Both Stuart-Harris22 and Sachs19 also reported a considerable reduc-
tion in mortality from epidemic typhus in the British Army following
the institution of prophylactic immunization. Their reports show that
the case fatality rate dropped to less than half that observed prior to
immunization.
The striking effect of immunization on reduction of mortality in
epidemic typhus fever, as shown above, is likewise brought out in the
data from the U. S. Army. In the 64 cases of epidemic typhus in the
Army for the period 1942 to 1946 not a single death was reported to
the War Department. This fact is perhaps the most striking observation
made in the present communication and can be ascribed to prophylactic
immunization with the Cox type ether-extracted vaccine. Indeed, Stuart-
Harris22 states that the American Army fighting alongside the British
in North Africa had only about a "score" of cases with no deaths during
the period that the British First Army had 41 cases with 13 deaths.
It is his opinion that the only difference was that the American Army
was immunized and that the difference in incidence and particularly the
absence of death was due to typhus vaccine.
Clinical records
Of the 64 cases of epidemic typhus reported from the U. S. Army,
adequate clinical records or abstracts of 5 cases have been obtained and
are briefly presented below. Abstracts of a few additional cases have
also been obtained, but are not sufficiently detailed to permit a proper
analysis of the clinical data and therefore are not included in the
present report.
Clinical data pertaining to the above-mentioned 5 cases are sum-
marized in Table 2, and serological findings and typhus immunization
records are presented in Table 3.
Case 1. A 41-year-old male officer, member of the U.S.A. Typhus Com-
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mission, was engaged in typhus research work in Cairo, Egypt, with Case 2 for
almost a month before the onset of the disease. Both were exposed daily to in-
fection with typhus by examining patients, picking infected lice off rabbits and
patients, and handling the grinding of infected louse feces for injection into
experimental animals. During the preceding two years, this officer had received
a total of 22 cc. of vaccine in single 1 cc. doses; 5 cc. of this vaccine was of
an experimental lot and contained both epidemic and murine virus. The last dose
of vaccine was received on 1 March 1944. Serology prior to infection was as
follows: On 21 March and 4 April 1944, the Weil-Felix reaction was negative,
but complement fixation was 1:8 with epidemic antigen and 1:4 with murine
antigen.
On 22 May 1944 the patient experienced a mild headache, general malaise,
and felt feverish. Although the headache became more severe and the temperature
ranged between 1000 and 101°F. during the next 3 days, he continued with
his typhus research activities. On the 5th day, 26 May, he took to his bed
because of headache, fatigue, and malaise. Backache was marked. The next day
he reported to a medical dispensary where physical examination revealed a few
pink papules on the left palm and wrist, a temperature of 99.2°F., and pulse of
100. The rash had disappeared by the following morning and except for a mild
headache, anorexia, and sense of fatigue, the patient did well on bed rest in
his quarters, reporting daily to the dispensary. He was afebrile by 28 May (7th
day) and was permitted to remain out of bed on 31 May (10th day).
Prior to the onset of typhus, the Weil-Felix reaction was negative with
both Proteus OX19 and OX2 antigens and the complement fixation titer was
1:8 with epidemic antigen and 1:4 with murine antigen. By the end of the first
week of disease the Proteus OX19 titer rose to 1:20, and in the second week
became 1:80. It reverted to negative in the 4th week. The complement fixation
titer rose rapidly to attain a titer of 1:1024 in the second week. Almost 2 years
later, the complement fixation (with epidemic antigen) was still positive at 1:10.
Case 2. A 35-year-old male officer, member of the U.S.A. Typhus Com-
mission, was engaged in typhus research in Cairo, Egypt, with Case 1 for over a
period of 1 month prior to onset of illness. While exposed daily, he recalled that
he was dangerously exposed on 11 June 1944 when he assisted with the handling
and grinding of infected louse feces in large amounts. During the period from
23 December 1941 to 10 October 1943, he received a total of 12 cc. of typhus
vaccine in 1 cc. doses. On 22 November 1943 he received 1 cc. of epidemic
typhus vaccine and on 10 April an additional and final dose of 1 cc. of vaccine.
Although the Weil-Felix reaction was negative with both Proteus OX19 and
ProteusOX2 antigens, the complement fixation titer with epidemic antigen was
1:8 three days before and 11 days after the last dose of vaccine.
On 23 June 1944, the patient awakened in the morning with a mild but
troublesome frontal headache which persisted through most of the day. The
following day the headache recurred together with malaise and easy fatigability.
His temperature was 1010F. These symptoms persisted with an increase in both
severity and extent of the headache so that he was admitted to the hospital late
in the afternoon of the next day, 25 June. The following day his temperature
was 100.4°F., pulse rate was 80, respiratory rate 20, blood pressure was 106/60.
Although he did not appear acutely ill, he complained of headache, chilly sen-
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sations, and nausea. Physical examination revealed only a marked injection of
the scleral conjunctivae. Later in the afternoon his temperature rose to 1020F.
and a diffuse macular eruption appeared over the anterior chest, arms, shoulders,
and flanks with an erythematous blush that disappeared upon pressure. He
continued that afternoon and night with slight chills. By the next morning the
rash had definitely faded but his headache, which was now generalized, became
exceptionally severe. Chills continued, and he appeared quite ill. There were
intermittent, drenching sweats, and he complained of severe backache and
general malaise. The temperature rose to 103.2OF. that night, but he had a pulse
rate of only 90. The respiratory rate was normal. Although the temperature fell
to 99.2°F. the following morning (28 June) and remained below 100.6°F.
throughout the course of the day, severe headache, malaise, sweating, and occa-
sional chills persisted. He vomited several times and on one occasion there was
a transient amnesia. During the course of the next 2 days, these symptoms still
persisted but the temperature remained relatively low and the rash became
increasingly less evident, and disappeared completely by 1 July. From 30 June
on, there was rapid and progressive improvement, as illustrated in Fig. 2, with fall
in temperature by rapid lysis, subsidence of headaches, malaise, nausea, and
vomiting, and rapid increase in serological titers for typhus fever. On 30 June,
there was a left earache but this disappeared within 48 hours without specific
therapy. Temperature was normal by 3 July. On 5 July he was permitted out
PULSE TEMPER-
ATURE
120 103 -O-O- PULSE
102
~ ~ ~
70
60 97 I_2 3_4 5_6 7_8 9_1_11 12 _3_1
DAY OF DISEASE 2 3 4 5 6 7 8 9 10 I1 12 13 14
OLOOD PRESSURE = 060 06/601106/60 1I06I/4 10%00104/sr 110Ol1I4/60
RESPIRATORY RATE + ] 20 0 |20 020|22 20 20 22 22 1 20 18 20201616 2020
HEADACHE + + F - 4* N4 I* + - - - - -
CHILL + + + - - _ - _ _ _
RASH - 4- 4 + 4 + - -
W*C X 1000 6.3 6.6
PROTEUS OXI9 - - _ _ _ 20 oleo 1.160 1 640
COMPL.; EPIDEMI*C = 8IS IS 1, 1.32 1.32 |.64 I2S 112s = 1.256 1 256
FIXATION -UIE _ _ _ _ _|_|_ _ t2 = 1D MURINE -
- - ~~~~~Ito 1.32 1.32 1.64
FIG. 2. Clinical course and early serological findings in Case 2, an example of moderately severe
epidemic typhus in a vaccinated individual.YAIE JOURNAL OF BIOLOGY AND MEDICINE
of bed and was discharged on the following day as an ambulatory patient.
During the course of his stay in the hospital there was no marked hypo-
tension. On 26 June, the day of admission, the red cell count was 4,600,000,
hemoglobin was 95 per cent, leukocyte count was 6,300 with 45 per cent
"stab" cells, 33 per cent polymorphonuclear neutrophils, 20 per cent lymphocytes,
and 2 per cent monocytes. On 3 July the blood count was as follows: red cells
4,650,000; hemoglobin 95 per cent; leukocytes 5,000 with 15 per cent "stab"
cells, 53 per cent polymorphonuclear neutrophils, 18 per cent lymphocytes, and
14 per cent monocytes. Urine examination on 26 June was negative.
Serological tests were performed daily during the acute phase of the disease.
The Weil-Felix reaction proteus OX19 antigen remained negative until the 8th
day when it became positive in a titer of 1:20. It then rose rapidly reaching
a top figure of 1:1280 on the 19th day. It was still positive at 1:80 on the 124th
day, but when next checked, almost 2 years after the onset of the disease, was
found to be negative. Complement fixing antibodies began to rise by the end of
the first week of disease, reaching a peak with epidemic antigen of 1:512 by
the 19th day. The titer began to fall after the 31st day and when last checked
almost 2 years later, the titer was still positive at 1:20. Specific rickettsial
agglutinations were negative at that time.
Case 3. A 36-year-old male officer, member of the U.S.A. Typhus Com-
mission, was engaged in typhus control work in Hokkaido, Japan. On 10
November 1945, he was heavily exposed in the room of a Japanese hospital to
dust containing suspended louse feces from the clothing of an active typhus
patient. From 17 February 1944 to 28 July 1944 he had received a total of
4 cc. of typhus vaccine in 1 cc. doses. On 9 May 1945 and 1 October 1945, he
received additional 1 cc. doses of the vaccine. On 6 June and 4 August 1945,
serology was as follows: Weil-Felix negative, complement fixation 1:10 with
epidemic antigen and negative with murine antigen, rickettsial agglutination
1:40 with epidemic antigen and negative with murine antigen.
On 22 November 1946, the patient experienced chilly sensations and gen-
eralized malaise. The following day headache, apathy, anorexia, and irritability
appeared. These persisted during the next 2 days with chilliness, and although
he felt feverish he did not take his temperature. On the 5th day, his temperature
was 101.8°F., pulse was 88, and respirations were 20. Headache became more
severe and was predominately bitemporal in location. A persistent dry hacking
cough set in and he vomited once. The next day, 6th day of disease, he refused
hospital admission but finally took to bed in his quarters. Headache became
excruciating in severity, temperature rose to 102.2°F., and nausea and cough
persisted. Although the temperature rose to 103.8°F. the night of the 7th day
and he became drowsy, there was suddenly a feeling of relative well-being the
following day with solution of fever by crisis and with profuse sweats. He was
afebrile by the 9th day, and was out of bed on the 10th day, and back to work
on the 13th day although he tired easily on exertion. The blood pressure re-
mained normal throughout and there was no rash. The lungs were clear.
The leukocyte count on the 7th day was 5,000. On the 13th day a complete
blood count at an out-patient clinic showed red cells 4,620,000, hemoglobin 90
per cent, leukocytes 6.600 with differential of 64 per cent "polys" and 36 per cent
"lymphocytes." On the 12th day urine was negative except for a faint trace of
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albumin with a few leukocytes in the microscopic examination. These findings
had disappeared by the following day. On the 21st day, electrocardiographic
tracing was normal in all 4 leads. The rate was 84, PR interval 0.16 sec., sinus
rhythm, QRS complexes 0.06 sec., T waves upright in all leads, no ST changes.
The serological changes are given in detail in Table 3. Briefly, Weil-Felix
reaction became positive on the 7th day with a titer of 1:40 and reached as
high as 1:80 by the 14th day. The complement fixation began to rise with epi-
demic antigen by the end of the first week, reached its peak at 1:1280 at the
end of the third week, and was still positive by the 9th month. Rickettsial
agglutination did not rise until the second week but reached is peak at that time
with a titer of 1:640 with epidemic antigen. It was still positive by the 9th month.
Case 4. A 32-year-old male officer was engaged in typhus control work in
Fischbach, Germany. On 23 March 1945, he and Case 5 were heavily exposed
to dust containing suspended louse feces in the room of a barracks (very re-
cently taken from the Germans) where louse-infested Russian typhus patients
were hospitalized. A Russian male nurse had just vigorously shaken out a shirt
belonging to one of the patients. Case 4 had received only three 1 cc. doses of
typhus vaccine, one week apart, in April and May of 1944. The first dose was
22 April 1944 and the last dose was 9 May 1944, a full year before infection.
The onset of illness was on 2 April 1945 with headache, chilliness, marked
fatigue, and mental depression. These symptoms persisted and on the following
day he had a shaking chill. The next day, 3rd day of disease, he was admitted
to the hospital for an elective surgical operation of minor nature. Although his
temperature at this time was 100°F., physical examination revealed no abnor-
malities. He was closely observed and on the 4th and 5th days, although his
temperature had risen to 103° with several shaking chills and with increase
in headache, backache, and generalized malaise, no findings of a diagnostic nature
other than cervical adenopathy and right upper quadrant pain were evident.
During the next 6 days his temperature ranged from 101°F. to 104.5°F. and
he complained bitterly of an excruciating headache. He was nauseated and
vomited. Malaria, meningitis, hepatitis, and infectious mononucleosis were con-
sidered in the differential diagnosis with typhus fever, although no definite
evidence could be obtained for any of these conditions. Finally, the diagnosis
was clarified on the 8th day by the appearance of a crop of pink macules over
the abdomen, chest, and back. This rash spread to the arms and to the legs by
the following day, but began to fade shortly thereafter on the 10th day, with
an abrupt fall in temperature on the 12th day. There were no hemorrhagic
residua. The fever, which fell by crisis, reached normal by the afternoon of the
11th day. On the 11th day he was permitted to get out of bed, and convalescence
was uneventful except for weakness and depression.
Many diagnostic procedures such as blood culture, lumbar puncture, blood
smears, various agglutinations, etc., were performed on this patient in the
early acute phase of the disease but were all essentially negative. X-ray of the
chest on the 9th day revealed clear lung fields. The leukocyte count on the
11th day was 7,000 with 70 per cent polymorphonuclear neutrophils, 20 per cent
"small" lymphocytes, 8 per cent "large" lymphocytes, and 2 per cent basophils;
on the 15th day the leukocyte count was 8,000 with an essentially normal differ-
ential. The Proteus OX19 agglutination titer rose from 1:40 on the 8th day
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to 1:640 on the 17th day. Epidemic complement fixation titer on the 23rd day
performed at the 1st Medical General Laboratory in Paris was 1:1024. Almost
a year later, this reaction was still positive in 1:20 while the Weil-Felix reaction
was negative.
Case 5. A 45-year-old male officer, was the chief medical officer of a Civil
Affairs unit in Germany and frequendy came into contact with typhus patients.
On 23 March 1945, he was heavily exposed to dust containing suspended louse
feces along with and under the same conditions as Case 4. He had received a
total of 8.5 cc. of typhus vaccine from August 1942 to 28 December 1944.
All of these doses were 1 cc. with the exception of a single dose of 0.5 cc.
On 22 March 1945 he received his final stimulating dose of 1 cc.
Illness began on 2 April 1945 with fever and headache. These symptoms
became progressively more severe, together with anorexia during the ensuing
5 days. Finally, when the headache became excruciating, and a non-productive
cough set in, he reported on the 8th day to a medical dispensary. His temperature
was 103°F. He was not hospitalized but was put to bed in his quarters. The
temperature progressively fell during the next several days, becoming normal
by the 13th day, and the headache abated. He returned to work on the 14th
day. There were no chills. Skin eruption was absent.
Appropriate laboratory procedures were not performed during the acute
stage to confirm the diagnosis. A blood specimen collected on the 20th day and
examined by the 1st Medical General Laboratory revealed a complement fixation
with epidemic antigen of 1:128 and with murine antigen of 1:64. Unfortu-
nately, no record exists of further specimens being examined for serology until
2 July 1945. This sample, examined at the Army Medical School in Washington,
indicated that the complement fixation titer had dropped but was still positive
in a titer of 1:40. Complement fixing antibodies were still present in titer of
1:20 almost a year after the onset of illness.
Clinical features of post-vaccination typhus
The clinical features of the 5 cases presented above are summarized
in Table 2. All of the individuals were male officers, three of them in
their thirties and two in the fifth decade of life. With the exception of
Case 4, all had received not only adequate amounts of vaccine but also
stimulating doses within 11 to 73 days prior to the onset of disease.
Case 4 had only an initial series of three 1 cc. doses of vaccine, the last
dose having been administered almost a full year before the onset of
typhus. In this connection it is interesting to note that he not only
suffered the most severe attack of typhus of any of the group, with
asthenia lasting well into late convalescence, but also presented a wide-
spread eruption over the entire trunk, legs, and arms. The incubation
period ranged from 10 to 13 days in the 3 cases in which it could be
accurately determined, was questionable at 12 days in one case, and was
less than 17 days in another. Only 2 of the 5 officers were sick enough
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TABLE 2
CLINICAL SUMMARY OF 5 CASES (MALE) OF EPIDEMIC TYPHUS FEVER INCURRED
SUBSEQUENT TO IMMUNIZATION WITH TYPHUS FEVER VACCINE
Typhus Case 1
vaccine Age41 yrs.
Total 22.0cc.
firstdose 21 Mar. 1942
lastdose 1 Mar. 1944
Onset of
disease 22 May 1944
Probable Laboratory,
mannerof pulmonary
infection inhalation
Incubation Less than
period 17 days
Wheretreated Quarters
Severity Mild
Day of fever
fromonset 6
Days inbed 3
Rash +
Headache ++
Confusion
Delirium
W.B.C.
Case 2
Age35 yrs.
14.0cc.
23 Dec. 1942
10 Apr. 1944
23 June 1944
Laboratory,
pulmonary
inhalation
? 12 days
Hospital
Mod. severe
10
10
++
Case3
Age 36 yrs.
6.0 cc.
17 Feb. 1944
1 Oct. 1945
22 Nov. 1945
Field,
pulmonary
inhalation
13 days
Quarters
Mild
9
5
6300;5600 5000;6600
to be admitted to the hospital, the others remaining in bed in their
quarters. Of particular interest is the short period for which they were
confined to bed. In 3 cases this was 5 days or less; in the remaining 2
instances, it was 10 and 11 days, respectively. The duration of fever
(more than 990F.) from onset of disease was likewise reduced in com-
parison with the average unvaccinated case, the values being 6, 10, 9,
11, and 12 days for Cases 1 to 5 respectively. Rash was absent in 2 of
the cases; when present, with the exception of Case 4, it was notstriking.
Central nervous system symptoms, except for headache, were con-
spicuous by their absence, although Case 2 was said to have shown
some indication of disorientation. This, however, was never clearly sub-
stantiated and definitely did not persist. Headache was severe in every
instance and was by far the most striking symptom of the disease.
Leukocyte counts were done in 3 cases during the course of the disease,
early and late. In no instance was there a leukocytosis, thus giving the
picture of an uncomplicated rickettsial disease. In classical typhus, early
counts not infrequently show a leukopenia, while later on in the disease
with the appearance of bacterial complications, the count rises rapidly
Case 5
Age 45 yrs.
9.5 cc.
Aug. 1944
22 Mar. 1945
2 Apr. 1945
Field,
pulmonary
inhalation
10 days
Quarters
Mild
12
5
Case 4
Age32 yrs.
2.0cc.
25 Apr. 1944
9May 1944
2 Apr. 1945
Field,
pulmonary
inhalation
10 days
Hospital
Mod. severe
11
11
7000;8000
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with an increase in the young neutrophilic fraction of the differential.
There was no evidence in any of the cases of undue prostration, or of
cardiovascular renal involvement.
The picture presented above is in decided contrast to the unvaccin-
ated case of classical typhus. Here the temperature may remain elevated
between 104 and 1060F. until the end of the second week, the patient
becomes delirious, comatose, and finally stuporous, and signs of cardio-
vascular and renal involvement may appear. The rash is extensive and
hemorrhagic, and convalescence is prolonged. Such an example is illus-
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FIG. 3. Clinical course and early serological findings in a case of epidemic typhus, an example of
severe typhus in a non-vaccinated individual. (Data furnished by Dr. A. Yeomans.)
trated in Fig. 3.
Of particular interest is the method of infection. In every instance
there was considerable evidence to indicate that infection was not sus-
tained by louse "bite" but rather by the inhalation or conjunctival ab-
sorption of suspended infected louse feces. It has been well known for
many years thatphysicians and nurses attending cases ofepidemic typhus
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fever contract the disease despite active and vigorous measures to pre-
vent louse infestation.
The clinical features of the 5 cases of post-vaccination epidemic
typhus described above are in general accord with those already de-
scribed for laboratory12 23 and field7 10 infections. These studies show
that the clinical course of epidemic typhus is greatly modified when
infection occurs subsequent to immunization with vaccine. Fever is
much lower and of shorter duration than in non-vaccinated cases, the
period of hospitalization (if at all necessary) is markedly reduced, the
extent and duration of rash are diminished, circulatory and nervous
symptoms are lessened, and the incidence of complications is brought
down to a very low figure. The most striking result of immunization,
however, is the fact that there has not been a single death reported in
the vaccinated series of any of these investigations. Indeed, we are not
aware of a single authentic death from epidemic typhus fever when the
disease was incurred subsequent to adequate immunization with ether-
extracted Cox type vaccine.
In many instances, the diagnosis of typhus is extraordinarily difficult
in vaccinated individuals because of the remarkable modification of the
clinical picture, and serologic procedures must be employed for con-
firmation. The only symptom which regularly remains is the severe
headache.
Time limits for protection following immunization
It is difficult at this time to state accurately the time limits within
which one may expect satisfactory protection from typhus after vaccina-
tion. It would appear, however, that protection is adequate up to a
year following vaccination and that there is little indication that vaccine
exerts a favorable action unless it is given at least 1½V2 or 2 weeks prior
to exposure.
Ecke and his colleagues10 observed, first, that there was no apparent
diminution in benefit up to 325 days following a dose of typhus vaccine;
and second, that while the course of illness was somewhat shorter and
milder in a group who were vaccinated within 1½V2 to 2 weeks prior to
the onset of the disease, fatality might occur. A 35-year-old male, who
was vaccinated 3 days before the onset of disease, died with epidemic
typhus. In the present report, Case 4 had not received vaccine for 11
months prior to the onset of disease. He ran a moderately severe course
and had a fairly extensive rash. In the light of this experience it would
appear reasonable to set a time limit for maximum effectiveness of
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vaccine not to exceed 6 months after the initial series or stimulating
dose; and not to expect suitable protection unless the vaccine has been
administered at least 4 weeks prior to the onset of disease or 2 weeks
before exposure. In this connection, Topping, Henderson, and
Bengston24 have shown the importance of the stimulating dose of
vaccine in producing a high titer antibody that will persist for a con-
siderable period of time.
Serological diagnosis
Certain peculiarities in the serological picture of typhus infection
following immunization and the diagnostic need for such tests warrant
a brief discussion of the serological diagnosis.
The discovery of the Weil-Felix agglutination test, employing sus-
pensions of certain strains of the proteus bacillus provided a serological
reaction which was extensively used in the diagnosis of typhus fever.
This reaction, while non-specific, was of great value. Subsequently it
became known that not only did this reaction fail to differentiate be-
tween certain members of the group of rickettsial diseases, but also that
it did not differentiate between epidemic and murine typhus. Such
differentiation is of great importance in survey and control work with
typhus fever. It also proved to be desirable in the case of troops who,
during the past war, became infected with typhus.
The successful effortof Cox4 in cultivating rickettsiae in the yolk-sac
of the fertile hen egg, and Craigie's6 demonstration of the ether method
of extracting such cultures led to the preparation of an antigen with
which appropriate serological studies could be performed. Bengston,1
using an antigen prepared in such manner, described a complement
fixation test for murine typhus. This complement fixation reaction, as
subsequently developed and elaborated, clearly differentiated typhus not
only from other rickettsial diseases, but also served to separate epidemic
from murine typhus, provided that certain precautions, as outlined by
Plotz, Wertman, and Bennett,17 were closely followed. These investiga-
tors showed that when the rickettsial suspensions were rendered free of
"'soluble antigen," specific complement fixing antigens were obtained
with which these closely related diseases could be differentiated.
The serologic response in acquired epidemic typhus fever is now
well defined and established.15 The presence of agglutinins in rising titer
for the proteus OX9 bacillus may be demonstrated between the fourth
to thirteenth day, usually about the beginning of the second week. The
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titer rises during the second week to reach its maximum in early con-
valescence and usually disappears about 3 months after onset. Comple-
ment fixing and rickettsial agglutinating antibodies can be demonstrated
during the second week of the disease. Rickettsial agglutination reaches
a non-significant titer in lateconvalescence, while the complement fixing
antibody seems to persist for years after an attack. Indeed, Plotz15 has
found complement fixing antibodies in epidemic and murine typhus as
long as 32 and 12 years, respectively, subsequent to the active infection.
Recently, the development of serologic response in man following
the administration of epidemic typhus vaccine has been studied by
Topping, Henderson, and Bengston24 and byZarafonetis.27 These studies
show thatwhile such vaccination calls forth epidemiccomplement fixing
antibodies in low titer, there is usually little or no response with the
Weil-Felix test. While there is an increase in complement fixation titer
as a result of "booster" or "stimulating" vaccination, the trend is still
for a return to the pre-booster level within several months after the
"booster" injection.
When an individual who has received typhus vaccine becomes in-
fected with epidemic typhus, the Weil-Felix, rickettsial agglutination,
and complement fixing antibodies appear somewhat earlier than in non-
vaccinated individuals,15' 28 but continue to rise and eventually yield
a serologic picture similar to that in the non-vaccinated case. In general,
the titer obtained with complement fixing epidemic antigen exceeds that
with murine antigen, but occasionally considerable cross-fixation may
be observed.16 Until further data are obtained, it is unwise to depend
solely upon the complement fixation reaction for differentiation between
epidemic and murine typhus in those individuals who have been pre-
viously vaccinated.
In the case of the individual who contracts murine typhus subse-
quent to immunization with epidemic typhus vaccine, Plotz and
Wertman,16 and Zarafonetis et al.28 have found that complement fixing
epidemic antibodies may be evoked in substantial titer, thus rendering
differentiation impossible by the complement fixation reaction alone.
Such differentiation, according to Plotz and Wertman,16 can only be
achieved by using the specific rickettsial agglutination test.
The serologic reactions presented in the 5 cases described in the
present report are summarized in Table 3. Agglutinins for the proteus
OX19 bacillus, while generally not present in the pre-infection stage,
appeared in low titer by the 7th to 9th day. In 2 of the 4 cases in which
this test was carried out, the titer never exceeded 1:80, while in the
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TABLE 3
SEROLOGICAL FINDINGS AND IMMUNIZATION RECORD IN 5 CASES OF EPIDEMIC TYPHUS FEVER
INCURRED SUBSEQUENT TO IMMUNIZATION WITH TYPHUS FEVER VACCINE
Typhus vaccine* Serological findings
Complement- Rickeusial
Date of Day .of Weil-Felixl fixation agglutination
serum specimen disease OX19 OX2 epidemic murine epidemic murine
(1944)
Case 1 21 Mar. -61 1:8 1:4
21 Feb. 1942 4 Apr. --47 - 1:8 1:4
to 31 Jan. 44 27 May 7 1:20 1:256 1:128
21.0cc. 31 May 9 1:80 - 1:1024 1:256
1 Mar. 1944 6 June 15 1:20 1:512 1:128
1.0cc. 10 June 19 1:20 1:512 1:256
13 June 22 1:20 1:512 1:256
17 June 26 - 1:512 1:128
21 June 30 1:512 1:128
24 June 33 - - 1:512 1:128
28 June 37 1:512 1:128
4 July 43 - 1:256 1:128
23 July 62 1:256 1:64
3 Aug. 73 - 1:256 1:32
29 Aug. 99 - 1:64 1:16
16 Sept. 117 - 1:64 1:16
(1946)
25 Sep. 644 1:10 -
(1944)
Case 2 7 Apr. -78 - - 1:8
23 Dec. 1941 21 Apr. -64 - - 1:8
to 10Oct.43 24June 2 1:8
12.0cc. 25 June 3 - 1:8
22 Nov. 1943 26 June 4 - 1:8
1.0cc. 30 June 8 1:20 1:128 1:8
10 Apr. 1944 2 July 10 1:80 1:128 1:32
1.0cc. 4 July 12 1:160 1:40 1:256 1:32
6 July 14 1:640 1:256 1:64
11 July 19 1:1280 - 1:512 1:64
23 July 31 1:640 1:40 1:512 1:64
29 Aug. 68 1:160 - 1:128 1:32
24 Oct. 124 1:80 1:128 1:16
(1946)
7 Feb. 594 - - 1:20
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TABLE 3
Continued
SEROLOGICAL FINDINGS AND IMMUNIZATION RECORD IN 5 CASES OF
INCURRED SUBSEQUENT TO IMMUNIZATION WITH TYPHUS
EPIDEMIC TYPHUS FEVER
FEVER VACCINE
Typhus vaccine* Serological findings
Complement- Rickettsial
Date of Dayof Weil-Felixt fixation agglutin
serum specimen disease OX19 OX2 epidemic murine epidemic murine
(1945)
Case 3 6 June -169 - 1:10 - 1:40
17 Feb. 1944 4 Aug. -110 - 1:10 1:40
to 28 July 44
4.0cc. 28 Nov. 7 1:40 - 1:40 1:40
9 May 1945 5 Dec. 14 1:80 - 1:640 1:160 1:640 1:80
1.0cc. 12 Dec. 21 1:80 1:1280 1:160 1:320 1:80
1 Oct. 1945 26 Dec. 35 1:80 1:80 1:640 1:160 1:320 1:80
1.0cc. (1946)
16 Jan. 56 1:40 1:320 1:80 1:160 1:40
6 Feb. 77 - 1:320 1:40 1:160 -
27 Feb. 98 - 1:320 1:40 1:160 -
26 Mar. 125 - 1:160 1:20 1:80
9 Nov. 253 - 1:40 1:80 1:40
(1945)
Case 4 9 Apr. 8 1:40
25 Apr. 1944 12 Apr. 11 1:40 1:40
1.0cc. 18 Apr. 17 1:640 1:640
2 May 1944 24 Apr. 23 1:1024 1:512
1.0cc. 25 Apr. 24 1:640
9 May 1944 (1946)
1.0cc. 4 Mar. 337 - 1:120 1:10 - -
(1945)
Case 5 21 Apr. 20
Aug. 1942 to 3 July 92 1:40 - 1:128 1:64
28 Dec. 1944 (1946)
8.5 cc. 3 Mar. 336 1:40 1:40 1:20 1:160
22 Mar. 1945 1:20 1:10
1.0 cc.
Cox type ether-extracted epidemic typhus vaccine.
t 5 cc. of this vaccine was an experimental bivalent type containing epidemic and murine rickettsiae.
4 All tests with antigen OXK were negative where such tests were made in cases 2, 3, and 4.
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remaining cases (Cases 2 and 5) the titer reached a peak of 1:1280
and 1:640 during thethird week. The titers dropped rapidly to negative,
except in Case 5 where a value of 1:40 was found almost a year fol-
lowing infection.
Complement fixing antibodies were found in low dilution in the
pre-infection period in all 3 instances in which the test was performed.
These titers (1:8, 1:8, 1:10) were due to immunization with vaccine.
In Case 2, where tests were carried out daily during the first week of
disease, the complement fixing titer rose from 1:8 to 1:32 on the 5th
day; to 1:64 on the 7th day; to 1:128 on the 8th day; to 1:256 on the
12th day; and to 1:512 on the 19th day. This illustrates in excellent
fashion the early and rapid rise of complement fixing antibodies in the
previously vaccinated individual. Although the serology was not fol-
lowed as early and as consistently in the remaining cases, the results
generally show that complement fixing antibodies were rising rapidly
by the end of the first week, to reach their peak in the second or third
week. Such peak titers ranged between 1:128 to 1:1280 in the 5 cases
studied and fell off slowly in late convalescence. The titer was still
positive at 1:10 in Case 1 almost 2 years after infection, at 1:20 in
Case 2 1½V2 years after infection, and at 1:20 in Cases 4 and 5 a year
after infection. In Case 3, the complement fixing titer remains positive
in a dilution of 1:40 nine months after onset of disease. In all instances
the differentiation with epidemic and murine antigens was clear cut.
Although the complement fixation titer obtained in Case 5 was
never above 1:128, a value which may be observed on occasion with
vaccination alone, the diagnosis of epidemic typhus seems valid on the
basis of persistence of such antibodies for a prolonged period and the
clinical history of exposure and onset of disease identical with that of
Case 4.
It was possible to obtain rickettsial agglutinations throughout the
course of disease only with Case 3. Here, the appearance and rise in titer
roughly paralleled that of the Weil-Felix reaction although higher
values were obtained and agglutinins persisted for a longer period of
time. In Case 2, where the test was performed almost 2 years after in-
fection, and in Cases 4 and 5 where the test was carried out 1 year sub-
sequent to the active attack the values were negative.
The above results are consistent with those already recorded in the
literature and confirm the usefulness ofthecomplementfixation reaction
and rickettsial agglutination test in the diagnosis of typhus following
vaccination. They also demonstrate that while the Weil-Felix may prove
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useful in such confirmation, the titers usually obtained are low and con-
clusions must be based on a series of examinations rather than on one
or two tests.
Summary
During the period from January 1, 1942, to December 31, 1945,
inclusive, there were reported from the entire U. S. Army, 64 cases of
epidemic (louse-borne) typhus, 603 cases of murine (endemic) typhus,
and 6,685 cases of scrub typhus (tsutsugamushi disease). There were
no deaths among the 64 cases of epidemic typhus.
While no definite conclusion may be reached concerning reduction
in incidence of epidemic typhus by prophylactic immunization with Cox
type ether-extracted typhus vaccine, the following points may be made:-
(1) Evidence is accumulating to suggest that such incidence may be
definitely lowered by adequate prophylactic immunization; (2) vaccina-
tion serves greatly to modify the disease if it occurs in an adequately
vaccinated individual; and (3) the chance of death from epidemic
typhus is rendered practically nil if a person has been adequately
immunized at least 2 weeks prior to exposure.
Clinical records and serological findings in 5 cases of epidemic
typhus fever occurring subsequent to prophylactic immunization are
presented. Complement fixing antibodies for epidemic typhus persisted
for prolonged periods, while the Weil-Felix reaction and the specific
rickettsial agglutination test became negative in late convalescence. In
all 5 cases it was highly probable that infection was sustained by pul-
monary inhalation orconjunctival absorption of dustcontaining infected
louse feces.
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